Xenon Pharmaceuticals (XENE) Insider Trading & Ownership → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free XENE Stock Alerts $39.50 -1.59 (-3.87%) (As of 04/24/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Xenon Pharmaceuticals (NASDAQ:XENE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.43%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$6.08 M Get XENE Insider Trade Alerts Want to know when executives and insiders are buying or selling Xenon Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address XENE Insider Buying and Selling by Quarter Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him Xenon Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/7/2024Sherrington RobinEVPSell7,137$46.28$330,300.36 3/7/2024Steven GannonDirectorSell13,000$46.28$601,640.00 12/13/2023Gary PatouDirectorSell11,380$39.29$447,120.20 8/24/2023Dawn SvoronosDirectorSell25,000$38.70$967,500.00 5/31/2023Simon N PimstoneDirectorSell62,526$38.70$2,419,756.20 5/24/2023Ian MortimerCEOSell31,655$41.41$1,310,833.55 (Data available from 1/1/2013 forward) XENE Insider Trading Activity - Frequently Asked Questions Who is on Xenon Pharmaceuticals's Insider Roster? The list of insiders at Xenon Pharmaceuticals includes Christopher John Kenney, Dawn Svoronos, Frank A Holler, Gary Patou, Ian Mortimer, James R Empfield, Seggern Christopher Von, Sherrington Robin, Simon N Pimstone, and Steven Gannon. Learn more on insiders at XENE. What percentage of Xenon Pharmaceuticals stock is owned by insiders? 5.43% of Xenon Pharmaceuticals stock is owned by insiders. Learn more on XENE's insider holdings. Which Xenon Pharmaceuticals insiders have been selling company stock? The following insiders have sold XENE shares in the last 24 months: Christopher John Kenney ($24,507.00), Dawn Svoronos ($967,500.00), Gary Patou ($585,125.24), Ian Mortimer ($1,310,833.55), James R Empfield ($2,212,134.33), Sherrington Robin ($330,300.36), Simon N Pimstone ($7,901,253.28), and Steven Gannon ($601,640.00). How much insider selling is happening at Xenon Pharmaceuticals? Insiders have sold a total of 357,444 Xenon Pharmaceuticals shares in the last 24 months for a total of $13,933,293.76 sold. More Insider Trading Tools from MarketBeat Related Companies: FOLD Insider Transactions IDYA Insider Transactions BHC Insider Transactions AXSM Insider Transactions ARWR Insider Transactions PBH Insider Transactions ACAD Insider Transactions MLTX Insider Transactions RARE Insider Transactions BHVN Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:XENE) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenon Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
